Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cypre
company
About
Cypre Inc. is a biotechnology company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cypre is dedicated to overcoming therapeutic resistance for cancer patients. They are applying the platform with therapeutic innovators for drug discovery and combination screening across various modalities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Cypre has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2018 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2018 | Convertable Note | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cypre is funded by 2 investors.
The Next Impact
and Novit Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
The Next Impact
|
— | Convertable Note |
|
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
